Quest Diagnostics(DGX) - 2024 Q3 - Quarterly Report

Revenue Performance - Net revenues for Q3 2024 increased to $2.488 billion, up from$2.295 billion in Q3 2023[123] - DIS revenues grew to $2.427 billion in Q3 2024, compared to$2.228 billion in Q3 2023[123] - Revenue per requisition increased by 3.3% in Q3 2024, reversing a 7.2% decline in Q3 2023[123] - Requisition volume rose by 5.5% in Q3 2024, compared to a 0.5% decline in Q3 2023[123] - DS revenues decreased to $61 million in Q3 2024 from$67 million in Q3 2023[123] Net Income - Net income attributable to Quest Diagnostics was $226 million in Q3 2024, slightly up from$225 million in Q3 2023[123] Acquisitions - The company completed the acquisition of LifeLabs for approximately USD $1 billion in August 2024[126] - Quest Diagnostics acquired select assets of PathAI Diagnostics for$100 million in June 2024[125] Cost Savings and Productivity - The Invigorate program aims to deliver 3% annual cost savings and productivity improvements[130] Restructuring and Integration Costs - The company incurred $45 million in pre-tax charges for restructuring and integration activities in the first nine months of 2024[131]